Biopharmaceuticals

News Biopharmaceuticals

• IMS Forecasts Global Pharmaceutical Market Growth of 5-8% Annually through 2014

  IMS Health reported that the size of the global market for pharmaceuticals is expected to grow nearly $300 billion (ex manufacturer prices) over the next five years, reaching $1.1 trillion in 2014. The 5 - 8 percent compound annual growth rate during this period reflects the impact of leading produc more

• Biomanufacturing Symposium at BIOTECHNICA 2009

  The second edition of this year’s Biomanufacturing Symposium on 7th October 2009 at BIOTECHNICA in Hannover (Germany), offers an ideal exchange platform for biopharma drug developers and manufacturers. This one-day event jointly organised by Capgemini Consulting and Deutsche Messe will address curre more

• CMC Acquires Former ICOS Biologics Operation in Bothell, Washington State, USA

  CMC Biopharmaceuticals A/S (CMC) announced that it has reached an agreement to buy the biologics development and manufacturing operation that Eli Lilly and Company acquired when it purchased ICOS Corporation in January 2007. CMC, a Copenhagen based leading provider of contract biomanufacturing servi more

White papers Biopharmaceuticals

• Characterizing Biotherapeutics with HPLC
  

  As demonstrated here, there are a broad range of HPLC applications used in development, production, validation and release of protein therapeutics for human use. Some of the applications mentioned above are mandatory when submitting a new biopharmaceutical to approval at the regulatory agencies. The introduction of the first so-called biosimilars in Europe further increased the demand for highly efficient analysis methods. The continuous development of new stationary phases for the common modes of biochromatography, such as size exclusion, ion exchange and hydrophilic interaction chromatography support biochemists in increasing lab productivity and establishing high-throughput HPLC analysis not only for small molecules but also for large biopolymers more

Publications Biopharmaceuticals

• IJMS, Vol. 14, Pages 8291-8305: Inhibition of Corneal Neovascularization with the Combination of Bevacizumab and Plasmid Pigment Epithelium-Derived Factor-Synthetic Amphiphile ...

  Chien-Neng Kuo 1,2,3,4, Chung-Yi Chen 5, San-Ni Chen 6,7, Lin-Cheng Yang 8, Li-Ju Lai 1,2,3, Chien-Hsiung Lai 1,2,3, Miao-Fen Chen 2,3,9, Chia-Hui Hung 2,3,10 and Ching-Hsein Chen 11,* 1 Department of Ophthalmology, Chang Gung Memorial Hospital, No.6, W. Sec., Jiapu Rd., Puzi City, Chiayi County more

• Sensitive Detection of Peptide–Minicircle DNA Interactions by Surface Plasmon Resonance

  Minicircle DNA (mcDNA) is recently becoming an exciting source of genetic material for therapeutic purposes due to its exceptional biocompatibility and efficiency over typical DNA. However, its widespread use is yet restrained because of the absence of an efficient technology that allows its purific more

• Development of a Convenient Competitive ELISA for the Detection of the Free and Protein-Bound Nonhuman Galactosyl-α-(1,3)-Galactose Epitope Based on Highly Specific Chicken Sin ...

  The presence of the nonhuman galactosyl-α-(1,3)-galactose (Gal-α-(1,3)-Gal) carbohydrate epitope on a number of recombinant therapeutic proteins has recently been reported, renewing interest in this immunogenic carbohydrate epitope. It is well-known that this motif is the primary contributing factor more

Market studies Biopharmaceuticals

• Guizhou Chitianhua Co.,Ltd. (600227) - Financial and Strategic SWOT Analysis Review

  Guizhou Chitianhua Co., Ltd. (Guizhou) is one of the leading manufacturers of fertilizers in China. The company is engaged in the production and sale of urea, phosphorus, nitrogen, special fertilizers, compound fertilizers, health food, functional food, and green environmental protection products. I more

Websites Biopharmaceuticals